HOME >> BIOLOGY >> NEWS
New research on safety of intracoronary delivery of adenovector reported in cover story of Molecular Therapy

th Collateral Therapeutics. This important new research effort at the University of Washington was undertaken as part of the current global development program for GENERX, which is focused on evaluating the safety and efficacy of GENERX in stable angina patients. GENERX is now in large-scale clinical trials in the U.S. and is expected to be in large-scale clinical trials in Europe in January 2002. Upon completion, it is expected that results of these studies, along with data from the other development activities could be used to support a marketing application for product registration to the U.S. Food and Drug Administration (FDA) and the European Medicines Evaluation Agency (EMEA).


'"/>

Contact: Lora Pike
lpike@collateralthx.com
858-794-3410
Collateral Therapeutics
1-Dec-2001


Page: 1 2 3

Related biology news :

1. Leader in cancer treatment and prevention research honored
2. UT Southwestern receives $1.78 million grant for obesity research as part of NIH Roadmap initiative
3. Scientists to prototype cyberinfrastructure for research and education access to ocean observatories
4. Belgian researchers explore revolutionary approach to angiogenesis
5. Award winning researchers reveal potential new role for Glivec
6. New research shows plants can shuffle and paste gene pieces to generate genetic diversity
7. 16 APS exercise research highlights, from reduced flu mortality to proteomics & obesity
8. Gene chips research in cotton could lead to superior variety
9. Groundbreaking research could ignite new solutions to heat transfer in nano-devices
10. New hydrothermal vents discovered as South Pacific Odyssey research begins
11. University of Alberta researcher looks for clues to mysterious disease

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/27/2019)... ... ... Though the forecast for the Thanksgiving holiday might look a bit grim, ... the roads and the skies. It’s a new personal recipe organizer app called MINE ... simple design, mouth-watering pictures of food, an optional social component and an easy-to-navigate recipe ...
(Date:11/22/2019)... ... 21, 2019 , ... The inventors of a new and ... major step forward with that therapy, known as SurVaxM. MimiVax LLC principals Robert ... from Roswell Park in 2012, has entered into a China-exclusive licensing agreement for ...
(Date:11/19/2019)... (PRWEB) , ... November 19, 2019 , ... The inaugural ... Times Square in New York City. The one-day event will be chaired by Dr ... of leaders in the space. , “We are witnessing significant innovation in cell ...
Breaking Biology News(10 mins):
(Date:12/18/2019)... , ... December 17, 2019 , ... ... is pleased to announce that it has hired Dr. Alia Orbin, Ph.D., ... Orbin is experienced in the preparation, filing and prosecution of patent applications related ...
(Date:12/4/2019)... ... 03, 2019 , ... A new survey by MedReps ( http://www.medreps.com ), a ... overall best medical sales companies to work for in 2020. , The ... professionals from the MedReps community to identify which medical sales companies are currently the ...
(Date:12/4/2019)... Indiana (PRWEB) , ... December 04, 2019 , ... ... strategy to further enhance dissolution and stabilize amorphous materials. Additionally, their PDF Synchrotron ... enhance the ability to describe these compositions both in regulatory and patent applications.  ...
(Date:11/22/2019)... (PRWEB) , ... November 22, ... ... chain engineering firm, hosted a live webinar covering a step-by-step cold chain ... antibodies, antibody-drug conjugates, and cell therapies. Targeting complex cold chain biopharmaceutical industry ...
Breaking Biology Technology:
Cached News: